Agilent Technologies (A) just rolled out an AI powered cell identification module for its BioTek Gen5 imaging software, aiming to simplify lab workflows and tighten consistency in cell based research assays.
Agilent Technologies has seen its share price climb 31.85% over the past 90 days and 24.91% year to date, while total shareholder return over one year sits at 25.09%. This suggests momentum has strengthened recently, even after a small 1-day pullback of 1.55%.
See how Agilent Technologies fits into the wider AI lab automation story by comparing it against a curated group of 37 profitable AI stocks that aren't just burning cash with real earnings behind their technology.
The AI launch, recent rally and solid reported revenue and net income growth fuel a bullish story. Skeptics see the stock as already well loved. Do Agilent Technologies’ current fundamentals justify this enthusiasm on price?
Most Popular Narrative: 1% Undervalued
Agilent Technologies closed at $172.31 against a narrative fair value of $174.90, so the story leans slightly in favor of the current price while still hinging on execution in its core tools and diagnostics lines.
Strategic investments in higher-margin recurring revenue streams, including consumables, software, services, and digital platforms, are gaining traction, with CrossLab and services delivering consistent mid-single-digit growth and high customer satisfaction, indicating further margin expansion and greater earnings stability in future periods.
See why 36 investors see Agilent Technologies as 1% undervalued.
Result: Fair Value of $174.90 (UNDERVALUED)
Still, the story can break if tariff costs remain elevated, or if academic and government lab budgets stay weak enough to dent Agilent Technologies’ instrument demand.
Find out about the key risks to this Agilent Technologies narrative.
Next Steps
Sentiment around Agilent Technologies is clearly optimistic right now, and the fastest edge often comes from checking the facts yourself before the crowd does. To see what that optimism is built on, take a closer look at the 3 key rewards.
Looking for more Agilent Technologies sized opportunities?
If you like what you see with Agilent Technologies, do not stop here. Cast a wider net with fresh ideas built from hard numbers and transparent fundamentals.
- Target resilient cash generators by tapping into a 33 high quality undervalued stocks that filters for quality businesses trading at prices some investors may overlook.
- Build a steadier income stream by scanning a focused set of 7 dividend fortresses that combine higher yields with disciplined fundamentals.
- Prioritize capital preservation by running through a 31 resilient stocks with low risk scores designed to spotlight companies with more robust risk profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com